Position in MNKD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,225,588
+$15,115,775 QoQ
Shares Held
3,808,824
+740.8% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 254 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. MNKD ranks #31 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in MNKD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,225,588 | 3,808,824 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,109,813 | 452,986 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,624,540 | 639,249 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,955,963 | 736,679 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $170,808 | 45,671 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $278,323 | 55,333 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $296,891 | 46,173 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $274,199 | 43,593 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $223,050 | 42,730 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $179,006 | 39,516 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $138,924 | 38,166 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $162,300 | 39,298 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $172,384 | 42,355 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $174,090 | 42,461 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $204,402 | 38,786 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $122,292 | 39,577 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $150,559 | 39,517 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $145,422 | 39,517 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $215,340 | 49,277 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $214,354 | 49,277 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $268,559 | 49,277 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $193,165 | 49,277 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $154,237 | 49,277 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $74,291 | 39,517 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||